DK0834312T3 - Topical drug based on diclofenac - Google Patents

Topical drug based on diclofenac

Info

Publication number
DK0834312T3
DK0834312T3 DK97117282T DK97117282T DK0834312T3 DK 0834312 T3 DK0834312 T3 DK 0834312T3 DK 97117282 T DK97117282 T DK 97117282T DK 97117282 T DK97117282 T DK 97117282T DK 0834312 T3 DK0834312 T3 DK 0834312T3
Authority
DK
Denmark
Prior art keywords
diclofenac
drug based
topical drug
topical
solubiliser
Prior art date
Application number
DK97117282T
Other languages
Danish (da)
Inventor
Gerhard Mueller
Original Assignee
Kade Pharma Fab Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kade Pharma Fab Gmbh filed Critical Kade Pharma Fab Gmbh
Application granted granted Critical
Publication of DK0834312T3 publication Critical patent/DK0834312T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

A medicament based on diclofenac or its salts, for topical treatment of inflammation and pain, contains at least one solvent and at least one solubiliser. The novelty is that contains at least one phospholipid.
DK97117282T 1996-10-07 1997-10-06 Topical drug based on diclofenac DK0834312T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19641259A DE19641259A1 (en) 1996-10-07 1996-10-07 Medicines based on diclofenac

Publications (1)

Publication Number Publication Date
DK0834312T3 true DK0834312T3 (en) 2003-04-22

Family

ID=7808045

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97117282T DK0834312T3 (en) 1996-10-07 1997-10-06 Topical drug based on diclofenac

Country Status (6)

Country Link
EP (1) EP0834312B1 (en)
AT (1) ATE230594T1 (en)
DE (2) DE19641259A1 (en)
DK (1) DK0834312T3 (en)
ES (1) ES2189910T3 (en)
PT (1) PT834312E (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19725615A1 (en) * 1997-06-17 1998-12-24 Permamed Ag Diclofenac solution intended for topical application
DE10024413A1 (en) * 2000-05-19 2001-12-06 Mika Pharma Gmbh Pharmaceutical and / or cosmetic preparation
ITMI20121205A1 (en) 2012-07-11 2014-01-12 Glycores 2000 Srl COMPOSITION WITH ANTI-INFLAMMATORY AND ANALGESIC ACTIVITY TO BE GIVEN FOR EXTERNAL USE BY VAPORIZATION
WO2023180792A1 (en) 2022-03-25 2023-09-28 Glycores 2000 Srl Topical pharmaceutical composition with anti-inflammatory and analgesic activity and uses thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3629412A (en) * 1969-09-19 1971-12-21 Merck & Co Inc Topical anti-inflammatory agent
GB2023000B (en) * 1978-06-17 1982-10-13 Kowa Co Antinflammatory analgesic gelled ointments
GB2075837B (en) * 1980-05-14 1984-03-14 Hisamitsu Pharmaceutical Co Topical pharmaceutical gel containing anti-inflammatory analgesic agents
CA1165240A (en) * 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
JPS5948413A (en) * 1982-09-14 1984-03-19 Grelan Pharmaceut Co Ltd Anti-inflammatory and analgesic agent for external use containing clidanac
CH655656B (en) * 1982-10-07 1986-05-15
DE3446873A1 (en) * 1984-12-21 1986-07-10 Merckle Gmbh LIQUID DICLOFENAC PREPARATIONS
IT1229489B (en) * 1988-12-09 1991-09-03 Altergon Sa PHARMACEUTICAL LIPID COMPOSITIONS FOR TOPICAL USE SUITABLE FOR VEHICULATING AN ACTIVE PRINCIPLE WATER-SOLUBLE ANTI-INFLAMMATORY
JP3340126B2 (en) * 1990-03-02 2002-11-05 株式会社資生堂 Oil-in-water emulsion composition containing non-steroidal anti-inflammatory drug
JPH04217925A (en) * 1990-03-27 1992-08-07 Nippon Saafuakutanto Kogyo Kk New antipyretic, antiphlogistic and analgesic agent composition
DE9016291U1 (en) * 1990-11-30 1991-03-28 Kali-Chemie Pharma Gmbh, 3000 Hannover Topically applicable diclofenac preparations
AU2259692A (en) * 1991-07-03 1993-02-11 Sano Corporation Composition and method for transdermal delivery of diclofenac
GB9212450D0 (en) * 1992-06-11 1992-07-22 Indena Spa New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them
CA2091152C (en) * 1993-03-05 2005-05-03 Kirsten Westesen Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
DE4313402A1 (en) * 1993-04-23 1994-10-27 Hexal Pharma Gmbh Transdermal preparation of active compound
US5744155A (en) * 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery
JPH07316075A (en) * 1994-05-26 1995-12-05 Pola Chem Ind Inc External preparation for skin
EP0704206B1 (en) * 1994-09-30 2002-09-04 MIKA Pharma Gesellschaft für die Entwicklung und Vermarktung pharmazeutischer Produkte mbH Pharmaceutical composition

Also Published As

Publication number Publication date
ATE230594T1 (en) 2003-01-15
EP0834312A1 (en) 1998-04-08
DE19641259A1 (en) 1998-04-16
EP0834312B1 (en) 2003-01-08
DE59709079D1 (en) 2003-02-13
ES2189910T3 (en) 2003-07-16
PT834312E (en) 2003-04-30

Similar Documents

Publication Publication Date Title
DK0659410T3 (en) Use of the active agent flupirtine in the manufacture of a drug for controlling muscle tension
ES2165910T3 (en) NASAL AND OCULAR CETAMINE ADMINISTRATION FOR THE TREATMENT OF PAIN AND FOR DETOXIFICATION.
KR920019342A (en) Bone Disease Treatment
DK0607128T3 (en) Drugs and their manufacture and use in the control of pain and / or inflammation in animals and humans
AR013742A1 (en) METHOD FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA WITH NON-SUBSTITUTED POLIDIALILAMINE
KR950002785A (en) Parathyroid hormone and raloxyphene to increase bone mass
NL1003300A1 (en) Implantable therapeutic device.
DK1075265T3 (en) Use of tetracyclines for the treatment of disease in the Meibomian glands
ATE69376T1 (en) HAIR GROWTH.
ES2093774T3 (en) STIMULATION OF WOUND HEALING WITH A COMPOUND 15-CETOPROSTAGLANDINA.
DK0907358T3 (en) Treatment with uniform drug delivery
NO973548L (en) Treatment of diabetic neuropathy
NO994165L (en) Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, travel sickness and dizziness
DE69130586D1 (en) Treatment of pancreatic disease with 15-keto-prostaglandin E derivatives
DK0781560T3 (en) Use of immunoglobulin preparations for the manufacture of a medicament for oral administration for treatment and prevention
DK0834312T3 (en) Topical drug based on diclofenac
NO984759D0 (en) Use of an osmolyte in the manufacture of a medicament for the treatment of complications caused by ischemia
BR9711575A (en) Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
DE69326627D1 (en) Therapeutic agent against impending abortion
DK0617959T3 (en) Medication for the treatment of skin diseases
DE68906513D1 (en) DICLOFENAC TOPIC APPLICATIONS.
BR9711329A (en) Use of pkc inhibitors for the manufacture of aids treatment drug
DK1235573T3 (en) Combination of riluzole and gabapentin and its use as a drug in the treatment of motor neuron disorders
PT834316E (en) USE OF SULBUTIAMINE FOR THE OBTAINMENT OF UTICAL PHARMACEUTICAL COMPOSITIONS IN THE TREATMENT OF CERTAIN PSYCHOMOTORAL AND PSYCHO-INTELLECTUAL PERTURBACES
SE9602262D0 (en) New use of cystine derivatives